Blueprint Medicines Corp Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 11,818 | 111,798 | 10,000 | |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 94.83 | 9,271 | 879,169 | 0 | 9.3 K to 0 (-100.00 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 96.08 | 1,600 | 153,728 | 9,271 | 10.9 K to 9.3 K (-14.72 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 96.69 | 947 | 91,565 | 10,871 | 11.8 K to 10.9 K (-8.01 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 11,818 | 111,798 | 11,818 | 0 to 11.8 K |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 71,000 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 99.00 | 4,600 | 455,400 | 0 | 4.6 K to 0 (-100.00 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 4,600 | 0 to 4.6 K |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 5,666 | 204,259 | 18,334 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 6,286 | 102,336 | 27,209 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 94.44 | 2,370 | 223,823 | 5,874 | 8.2 K to 5.9 K (-28.75 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 95.53 | 2,549 | 243,506 | 8,244 | 10.8 K to 8.2 K (-23.62 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 96.35 | 2,977 | 286,834 | 10,793 | 13.8 K to 10.8 K (-21.62 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 97.39 | 2,123 | 206,759 | 13,770 | 15.9 K to 13.8 K (-13.36 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 98.63 | 1,000 | 98,630 | 15,893 | 16.9 K to 15.9 K (-5.92 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.02 | 933 | 93,319 | 16,893 | 17.8 K to 16.9 K (-5.23 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 5,666 | 204,259 | 17,826 | 12.2 K to 17.8 K (+46.60 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 6,286 | 102,336 | 12,160 | 5.9 K to 12.2 K (+107.01 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 5,000 | 9,350 | 38,080 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.06 | 5,000 | 495,300 | 28,961 | 34 K to 29 K (-14.72 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 5,000 | 9,350 | 33,961 | 29 K to 34 K (+17.26 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 100.00 | 568 | 56,800 | 4,735 | 5.3 K to 4.7 K (-10.71 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 96.99 | 568 | 55,090 | 5,303 | 5.9 K to 5.3 K (-9.67 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 575 | 5,060 | 4,879 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 830 | 1,552 | 14,259 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 100.00 | 575 | 57,500 | 0 | 575 to 0 (-100.00 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 96.99 | 830 | 80,502 | 575 | 1.4 K to 575 (-59.07 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 575 | 5,060 | 1,405 | 830 to 1.4 K (+69.28 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 830 | 1,552 | 830 | 0 to 830 |
| Jun 17 2019 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 90.00 | 568 | 51,120 | 5,871 | 6.4 K to 5.9 K (-8.82 %) |
| Jun 17 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 90.36 | 25,000 | 2,259,000 | 127,727 | 152.7 K to 127.7 K (-16.37 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 1,660 | 3,104 | 15,089 | |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 830 | 1,552 | 16,749 | |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 90.00 | 1,660 | 149,400 | 0 | 1.7 K to 0 (-100.00 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 1,660 | 3,104 | 1,660 | 0 to 1.7 K |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 85.00 | 830 | 70,550 | 0 | 830 to 0 (-100.00 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 830 | 1,552 | 830 | 0 to 830 |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 85.00 | 243 | 20,655 | 0 | 243 to 0 (-100.00 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 81.96 | 300 | 24,588 | 152,727 | 153 K to 152.7 K (-0.20 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 82.45 | 2,000 | 164,900 | 153,027 | 155 K to 153 K (-1.29 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 83.83 | 5,200 | 435,916 | 155,027 | 160.2 K to 155 K (-3.25 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 84.66 | 6,300 | 533,358 | 160,227 | 166.5 K to 160.2 K (-3.78 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 85.75 | 11,200 | 960,400 | 166,527 | 177.7 K to 166.5 K (-6.30 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 43,080 | |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 82.37 | 1,900 | 156,503 | 28,961 | 30.9 K to 29 K (-6.16 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 83.81 | 4,050 | 339,431 | 30,861 | 34.9 K to 30.9 K (-11.60 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 84.61 | 4,859 | 411,120 | 34,911 | 39.8 K to 34.9 K (-12.22 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 85.72 | 9,191 | 787,853 | 39,770 | 49 K to 39.8 K (-18.77 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 48,961 | 29 K to 49 K (+69.06 %) |